{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:49:51Z","timestamp":1740152991296,"version":"3.37.3"},"reference-count":53,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/13696998.2023.2194803","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T13:06:50Z","timestamp":1681218410000},"page":"554-564","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy"],"prefix":"10.1080","volume":"26","author":[{"given":"Eugenio","family":"Di Brino","sequence":"first","affiliation":[{"name":"Altems Advisory SRL, Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songkai","family":"Yan","sequence":"additional","affiliation":[{"name":"CSL Behring King of Prussia, King of Prussia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radovan","family":"Tomic","sequence":"additional","affiliation":[{"name":"CSL Behring, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Panebianco","sequence":"additional","affiliation":[{"name":"CSL Behring, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Dlotko","sequence":"additional","affiliation":[{"name":"Certara USA Inc., New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Stern","sequence":"additional","affiliation":[{"name":"Certara USA Inc., New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Basile","sequence":"additional","affiliation":[{"name":"Altems Advisory SRL, Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Rumi","sequence":"additional","affiliation":[{"name":"Altems Advisory SRL, Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Americo","family":"Cicchetti","sequence":"additional","affiliation":[{"name":"Altems Advisory SRL, Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Marino","sequence":"additional","affiliation":[{"name":"University Hospital of Bari, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_7_3_1","first-page":"53","volume-title":"Registro Nazionale delle Coagulopatie Congenite","author":"Abbonizio F","year":"2020","unstructured":"Abbonizio F, Arcieri R, Associazione Italiana Centri Emofilia (AICE), et\u00a0al. Registro Nazionale delle Coagulopatie Congenite (Rapporto 2018. (Rapporti ISTISAN 20\/14). Roma: istituto Superiore di Sanit\u00e0; 2020. p. 53."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00278-x"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.06.002"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"issue":"3","key":"e_1_3_7_7_1","first-page":"S567","article-title":"The social burden and quality of life of patients with haemophilia in Italy","volume":"12","author":"Kodra Y","year":"2014","unstructured":"Kodra Y, Cavazza M, Schieppati A, et\u00a0al. The social burden and quality of life of patients with haemophilia in Italy. Blood Transfus. 2014;12(Suppl 3):S567\u2013S75.","journal-title":"Blood Transfus"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0660-y"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.06.017"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1416088"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-687434"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123981"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13647"},{"issue":"1","key":"e_1_3_7_14_1","first-page":"PB0980","article-title":"Real-World experience of rVIII-SingleChain treatment in a French single center","volume":"4","author":"Hassoun AA.","year":"2020","unstructured":"Hassoun AA. Real-World experience of rVIII-SingleChain treatment in a French single center. Res Pract Thromb Haemost. 2020;4(Suppl 1):PB0980.","journal-title":"Res Pract Thromb Haemost"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.19318"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20199"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2062180"},{"key":"e_1_3_7_18_1","unstructured":"[online] BIA. York; York Health Economics Consortium 2016 [cited 2022 April]. Available from: https:\/\/yhec.co.uk\/glossary\/budget-impact-analysis\/."},{"key":"e_1_3_7_19_1","volume-title":"Registro Nazionale delle Coagulopatie Congenite. Rapporto 2013. (Rapporti ISTISAN 15\/14)","author":"Abbonizio F","year":"2015","unstructured":"Abbonizio F, Giampaolo A, Arcieri R, et\u00a0al. Registro Nazionale delle Coagulopatie Congenite. Rapporto 2013. (Rapporti ISTISAN 15\/14). Roma: Istituto Superiore di Sanit\u00e0; 2015."},{"key":"e_1_3_7_20_1","volume-title":"Registro Nazionale delle Coagulopatie Congenite. Rapporto 2014. (Rapporti ISTISAN 16\/20)","author":"Abbonizio F","year":"2016","unstructured":"Abbonizio F, Giampaolo A, Arcieri R, et\u00a0al. Registro Nazionale delle Coagulopatie Congenite. Rapporto 2014. (Rapporti ISTISAN 16\/20). Roma: Istituto Superiore di Sanit\u00e0; 2016."},{"key":"e_1_3_7_21_1","volume-title":"Registro Nazionale delle Coagulopatie Congenite. Rapporto 2015. (Rapporti ISTISAN 17\/14","author":"Abbonizio F","year":"2017","unstructured":"Abbonizio F, Giampaolo A, Arcieri R, et\u00a0al. Registro Nazionale delle Coagulopatie Congenite. Rapporto 2015. (Rapporti ISTISAN 17\/14). Istituto Superiore di Sanit\u00e0; 2017."},{"key":"e_1_3_7_22_1","volume-title":"Registro Nazionale delle Coagulopatie Congenite. Rapporto 2016. (Rapporti ISTISAN 17\/44)","author":"Abbonizio F","year":"2017","unstructured":"Abbonizio F, Giampaolo A, Riccioni R, et\u00a0al. Registro Nazionale delle Coagulopatie Congenite. Rapporto 2016. (Rapporti ISTISAN 17\/44). Istituto Superiore di Sanit\u00e0; 2017."},{"key":"e_1_3_7_23_1","volume-title":"Registro Nazionale delle Coagulopatie Congenite. Rapporto 2017. (Rapporti ISTISAN 19\/8)","author":"Abbonizio F","year":"2019","unstructured":"Abbonizio F, Hassan H, Riccioni R, et\u00a0al. Registro Nazionale delle Coagulopatie Congenite. Rapporto 2017. (Rapporti ISTISAN 19\/8). Istituto Superiore di Sanit\u00e0; 2019."},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13111"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.2396"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1875788"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2021.07.003"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3398-x"},{"key":"e_1_3_7_29_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 AFSTYLA; 2019. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/afstyla-epar-product-information_en.pdf."},{"key":"e_1_3_7_30_1","unstructured":"European Medicine Agency. Summary of product characteristics \u2013 ELOCTA; 2020. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/elocta-epar-product-information_en.pdf."},{"key":"e_1_3_7_31_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 ADYNOVI; 2019. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/adynovi-epar-product-information_en.pdf."},{"key":"e_1_3_7_32_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 NUWIQ. 2019. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/nuwiq-epar-product-information_en.pdf."},{"key":"e_1_3_7_33_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 REFACTO AF. 2019. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/refacto-af-epar-product-information_en.pdf."},{"key":"e_1_3_7_34_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 JIVI; 2020. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/jivi-epar-product-information_en.pdf."},{"key":"e_1_3_7_35_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 ESPEROCT; 2020. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/esperoct-epar-product-information_en.pdf."},{"key":"e_1_3_7_36_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 KOVALTRY; 2020. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kovaltry-epar-product-information_en.pdf."},{"key":"e_1_3_7_37_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 ADVATE; 2020. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/advate-epar-product-information_en.pdf."},{"key":"e_1_3_7_38_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 NOVOEIGHT; 2020. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/novoeight-epar-product-information_en.pdf."},{"key":"e_1_3_7_39_1","unstructured":"European Medicines Agency. Summary of product characteristics \u2013 HEMLIBRA; 2021. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/hemlibra-epar-product-information_en.pdf."},{"key":"e_1_3_7_40_1","unstructured":"Gazzetta Ufficiale Serie Generale. 158(191) 17-08-2017. [cited]. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2017\/08\/17\/191\/sg\/pdf."},{"key":"e_1_3_7_41_1","unstructured":"Gazzetta Ufficiale Serie Generale. 157(174) 27-07-2016. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2016\/07\/27\/174\/sg\/pdf."},{"key":"e_1_3_7_42_1","unstructured":"Gazzetta Ufficiale Serie Generale. 161(14) 18-01-2020. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2020\/01\/18\/14\/sg\/pdf."},{"key":"e_1_3_7_43_1","unstructured":"Gazzetta Ufficiale Serie Generale. 161(21) 27-01-2020. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2020\/01\/27\/21\/sg\/pdf."},{"key":"e_1_3_7_44_1","unstructured":"Gazzetta Ufficiale Serie Generale. 178(76) 16-07-2020. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2020\/07\/16\/178\/so\/24\/sg\/pdf."},{"key":"e_1_3_7_45_1","doi-asserted-by":"crossref","unstructured":"Gazzetta Ufficiale Serie Generale. 163(52) 03-03-2022. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2022\/03\/03\/52\/sg\/pdf.","DOI":"10.1055\/a-1720-9559"},{"key":"e_1_3_7_46_1","unstructured":"Gazzetta Ufficiale Serie Generale. 156(125) 01-06-2015. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2015\/06\/01\/125\/sg\/pdf."},{"key":"e_1_3_7_47_1","unstructured":"Gazzetta Ufficiale Serie Generale. 156(198) 27-08-2015. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2015\/08\/27\/198\/sg\/pdf."},{"key":"e_1_3_7_48_1","doi-asserted-by":"crossref","unstructured":"Gazzetta Ufficiale Serie Generale. 152(298) 23-12-2011. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2011\/12\/23\/298\/sg\/pdf.","DOI":"10.1007\/BF03363997"},{"key":"e_1_3_7_49_1","unstructured":"Gazzetta Ufficiale Serie Generale. 155(190) 18-08-2014. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2014\/08\/18\/190\/sg\/pdf."},{"key":"e_1_3_7_50_1","unstructured":"Gazzetta Ufficiale Serie Generale. 161(71) 18-03-2020. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2020\/03\/18\/71\/sg\/pdf."},{"key":"e_1_3_7_51_1","unstructured":"Biogen Canada Inc. Product monograph \u2013 ELOCTATE; 2016. Available from: https:\/\/www.biogen.ca\/content\/dam\/corporate\/en_CA\/pdfs\/products\/ELOCTATE\/ELOCTATE_PM_E.pdf."},{"key":"e_1_3_7_52_1","unstructured":"Novo Nordisk Canada Inc. Product monograph \u2013 ESPEROCT; 2020. Available from: https:\/\/www.novonordisk.ca\/content\/dam\/nncorp\/ca\/en\/products\/esperoct-product-monograph.pdf."},{"key":"e_1_3_7_53_1","unstructured":"Octapharma Canada Inc. Product monograph \u2013 NUWIQ; 2018. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00044390.pdf."},{"key":"e_1_3_7_54_1","unstructured":"Shire Pharma Canada ULC. Product monograph \u2013 ADVATE; 2018. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00046596.pdf."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2023.2194803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T10:08:51Z","timestamp":1701943731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2023.2194803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/13696998.2023.2194803"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2023.2194803","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"type":"print","value":"1369-6998"},{"type":"electronic","value":"1941-837X"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}